Renovaro Inc. has announced the receipt of a Notice of Allowance from the United States Patent and Trademark Office for a new patent application titled "Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions." This patent enhances Renovaro's intellectual property portfolio by securing methods for integrating and harmonizing diverse biomedical data sources into a standardized framework for predictive modeling. This strategic milestone strengthens their position in the data-driven therapeutics market, addressing challenges in pharmaceutical R&D by improving data integration and analytics. The patent also supports Renovaro's revenue growth strategy by protecting its technology approach, which is crucial for commercial partnerships and platform deployment in life sciences and healthcare.